1) Begin with low-dose metformin (500 mg ... Lilly, Novo Nordisk, Merck, Novartis, Pfizer, and Sanofi-Aventis. Dislcosure: M.B.D. has received research support from Eli Lilly, Merck, and Pfizer ...

Hopewell Pharma Ventures Inc. convinced a federal judge to stay Merck Serono SA’s lawsuit alleging infringement related to its Mavenclad multiple sclerosis treatment after two of the patents were ...

1000 mg XR tablet of Laboratorios Leti S.A.V., with Glucophage® (metformin hydrochloride) 1000 mg XR tablet of Merck Serono GmbH in 26 adult healthy subjects. The pharmacokinetic (PK) parameters Cmax, ...

Dec 23 (Reuters) - Merck (MRK.N), opens new tab will discontinue its drug for a bacterial infection that can lead to fatal diarrhea, the U.S. Food and Drug Administration's website showed on Monday.

Merck just closed a deal to develop a weight-loss drug. The market appears to think Viking Therapeutics is threatened by that data. There's little reason to write off Viking here. First, let's get ...

Merck in-licensed a preclinical oral GLP-1 candidate from China's Hansoh Pharma. Astellas doubled down in gene therapy with a viral capsid deal with Sangamo Therapeutics. Betta Pharma's Ensacove ...

RAHWAY, N.J., December 20, 2024--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the closing of the exclusive global license agreement for ...

A new evidence-based guideline recommends prescribing metformin when initiating antipsychotic treatment to help mitigate weight gain in certain instances. There is “good evidence” that ...

The products were sold as herbal supplements intended to support blood sugar balance, but they contain prescription-grade diabetes drugs metformin and glyburide, which both can come with fatal ...

Merck's DOR/ISL regimen demonstrated non-inferiority to bART and BIC/FTC/TAF in two pivotal Phase 3 trials for adults with HIV-1. Both trials achieved primary safety objectives, with detailed ...

After hitting the mark in a phase 2 of its investigational islatravir paired with Gilead Sciences' lenacapivir, Merck & Co.'s islatravir is making further strides as a combination treatment with ...